E Genton. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AnimalsEndopeptidases/therapeutic useHemorrhage/chemically inducedHeparin/adverse effectsHeparin/therapeutic useHumansPulmonary Embolism/drug therapyPulmonary Embolism/mortalityStreptokinase/administration & dosageStreptokinase/adverse effectsStreptokinase/therapeutic useUrokinase-Type Plasminogen Activator/administration & dosageUrokinase-Type Plasminogen Activator/adverse effectsUrokinase-Type Plasminogen Activator/therapeutic use
Substances： See more » HeparinEndopeptidasesStreptokinaseUrokinase-Type Plasminogen Activator
Year: 1979 PMID： 419322 DOI： 10.1016/0033-0620(79)90006-9
Source DB: PubMed Journal: Prog Cardiovasc Dis ISSN： 0033-0620 Impact factor: 8.194